Neogen Net Worth
Neogen Net Worth Breakdown | NEOG |
Neogen Net Worth Analysis
Neogen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Neogen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Neogen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Neogen's net worth analysis. One common approach is to calculate Neogen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Neogen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Neogen's net worth. This approach calculates the present value of Neogen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Neogen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Neogen's net worth. This involves comparing Neogen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Neogen's net worth relative to its peers.
Enterprise Value |
|
To determine if Neogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Neogen's net worth research are outlined below:
| Neogen generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 822.45 M. Net Loss for the year was (22.87 M) with profit before overhead, payroll, taxes, and interest of 409.2 M. | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Theres Reason For Concern Over Neogen Corporations Price |
Neogen Quarterly Good Will |
|
Neogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Neogen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 25th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Neogen Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Neogen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Neogen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Buy |
Most Neogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Neogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Neogen, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNeogen Target Price Projection
Neogen's current and average target prices are 13.37 and 22.25, respectively. The current price of Neogen is the price at which Neogen is currently trading. On the other hand, Neogen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Neogen Target Price
Know Neogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Neogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neogen backward and forwards among themselves. Neogen's institutional investor refers to the entity that pools money to purchase Neogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rivulet Capital, Llc | 2024-03-31 | 5.9 M | Mackenzie Investments | 2023-12-31 | 5.9 M | Champlain Investment Partners, Llc | 2024-03-31 | 5.6 M | T. Rowe Price Investment Management,inc. | 2023-12-31 | 5.4 M | Geode Capital Management, Llc | 2023-12-31 | 4.7 M | Jpmorgan Chase & Co | 2023-12-31 | 3.9 M | Northern Trust Corp | 2023-12-31 | 3.8 M | Hhg Plc | 2024-03-31 | 3.6 M | Brown Capital Management, Llc | 2023-12-31 | 3.4 M | Blackrock Inc | 2023-12-31 | 24.9 M | Vanguard Group Inc | 2024-03-31 | 19.7 M |
Follow Neogen's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Neogen's market, we take the total number of its shares issued and multiply it by Neogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Project Neogen's profitablity
Neogen's profitability indicators refer to fundamental financial ratios that showcase Neogen's ability to generate income relative to its revenue or operating costs. If, let's say, Neogen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Neogen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Neogen's profitability requires more research than a typical breakdown of Neogen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.03) | (0.02) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0) | (0) | |
| Return On Equity | (0.01) | (0.01) |
When accessing Neogen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Neogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Neogen's profitability and make more informed investment decisions.
The data published in Neogen's official financial statements usually reflect Neogen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Neogen. For example, before you start analyzing numbers published by Neogen accountants, it's critical to develop an understanding of what Neogen's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Neogen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neogen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Neogen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Neogen. Please utilize our Beneish M Score to check the likelihood of Neogen's management manipulating its earnings.
Evaluate Neogen's management efficiency
Neogen has return on total asset (ROA) of 0.0179 % which means that it generated a profit of $0.0179 on every $100 spent on assets. This is way below average. Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities. The Neogen's current Return On Tangible Assets is estimated to increase to -0.02. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Neogen's Other Current Assets are most likely to increase significantly in the upcoming years. The Neogen's current Total Current Assets is estimated to increase to about 707.5 M, while Other Assets are projected to decrease to roughly 16.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.93 | 15.68 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | (10.68) | (10.14) | |
| Enterprise Value Over EBITDA | 96.93 | 101.77 | |
| Price Book Value Ratio | 0.95 | 0.90 | |
| Enterprise Value Multiple | 96.93 | 101.77 | |
| Price Fair Value | 0.95 | 0.90 | |
| Enterprise Value | 3.6 B | 3.8 B |
The analysis of Neogen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Neogen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Neogen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 3.6602 | Revenue 929.2 M | Quarterly Revenue Growth 0.048 | Revenue Per Share 4.293 | Return On Equity 0.0005 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
James Tobin over three weeks ago Acquisition by James Tobin of 3000 shares of Neogen at 15.189 subject to Rule 16b-3 | ||
Amy Rocklin over three weeks ago Disposition of 563 shares by Amy Rocklin of Neogen at 11.96 subject to Rule 16b-3 | ||
Moylan John Patrick over a month ago Insider Trading | ||
Clayton Yeutter over six months ago Purchase by Clayton Yeutter of 500 shares of Neogen | ||
James Tobin over six months ago Exercise or conversion by James Tobin of 13716 shares of Neogen subject to Rule 16b-3 | ||
Satoh Paul S over a year ago Sale by Satoh Paul S of 1500 shares of Neogen |
Neogen Corporate Filings
F4 | 3rd of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 17th of April 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 9th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Neogen Earnings Estimation Breakdown
The calculation of Neogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Neogen is estimated to be 0.11 with the future projection ranging from a low of 0.115 to a high of 0.115. Please be aware that this consensus of annual earnings estimates for Neogen is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.12 Lowest | Expected EPS | 0.12 Highest |
Neogen Earnings Projection Consensus
Suppose the current estimates of Neogen's value are higher than the current market price of the Neogen stock. In this case, investors may conclude that Neogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Neogen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of May 2024 | Current EPS (TTM) | |
| 7 | 21.78% | 0.12 | 0.11 | 0.02 |
Neogen Earnings History
Earnings estimate consensus by Neogen analysts from Wall Street is used by the market to judge Neogen's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Neogen's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Neogen Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neogen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neogen Earnings per Share Projection vs Actual
Actual Earning per Share of Neogen refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Neogen predict the company's earnings will be in the future. The higher the earnings per share of Neogen, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Neogen Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Neogen, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Neogen should always be considered in relation to other companies to make a more educated investment decision.Neogen Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Neogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-04-09 | 2024-02-29 | 0.14 | 0.12 | -0.02 | 14 | ||
2024-01-09 | 2023-11-30 | 0.14 | 0.11 | -0.03 | 21 | ||
2023-10-10 | 2023-08-31 | 0.13 | 0.11 | -0.02 | 15 | ||
2023-07-27 | 2023-05-31 | -0.04 | 0.14 | 0.18 | 450 | ||
2023-03-30 | 2023-02-28 | -0.01 | 0.04 | 0.05 | 500 | ||
2023-01-05 | 2022-11-30 | 0.03 | -0.19 | -0.22 | 733 | ||
2022-09-27 | 2022-08-31 | 0.14 | 0.05 | -0.09 | 64 | ||
2022-07-26 | 2022-05-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2022-03-24 | 2022-02-28 | 0.15 | 0.05 | -0.1 | 66 | ||
2021-12-21 | 2021-11-30 | 0.17 | 0.1 | -0.07 | 41 | ||
2021-09-21 | 2021-08-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2021-07-20 | 2021-05-31 | 0.17 | 0.15 | -0.02 | 11 | ||
2021-03-23 | 2021-02-28 | 0.13 | 0.13 | 0.0 | 0 | ||
2020-12-22 | 2020-11-30 | 0.16 | 0.15 | -0.01 | 6 | ||
2020-09-22 | 2020-08-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2020-07-21 | 2020-05-31 | 0.15 | 0.16 | 0.01 | 6 | ||
2020-03-24 | 2020-02-29 | 0.14 | 0.12 | -0.02 | 14 | ||
2019-12-23 | 2019-11-30 | 0.16 | 0.16 | 0.0 | 0 | ||
2019-09-24 | 2019-08-31 | 0.15 | 0.14 | -0.01 | 6 | ||
2019-07-23 | 2019-05-31 | 0.15 | 0.15 | 0.0 | 0 | ||
2019-03-26 | 2019-02-28 | 0.14 | 0.13 | -0.01 | 7 | ||
2018-12-20 | 2018-11-30 | 0.15 | 0.16 | 0.01 | 6 | ||
2018-09-25 | 2018-08-31 | 0.14 | 0.14 | 0.0 | 0 | ||
2018-07-17 | 2018-05-31 | 0.15 | 0.17 | 0.02 | 13 | ||
2018-03-22 | 2018-02-28 | 0.12 | 0.11 | -0.01 | 8 | ||
2018-01-03 | 2017-11-30 | 0.13 | 0.13 | 0.0 | 0 | ||
2017-09-19 | 2017-08-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2017-07-18 | 2017-05-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2017-03-21 | 2017-02-28 | 0.1 | 0.1 | 0.0 | 0 | ||
2016-12-21 | 2016-11-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2016-09-27 | 2016-08-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2016-07-19 | 2016-05-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2016-03-23 | 2016-02-29 | 0.09 | 0.08 | -0.01 | 11 | ||
2015-12-21 | 2015-11-30 | 0.1 | 0.09 | -0.01 | 10 | ||
2015-09-21 | 2015-08-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2015-07-21 | 2015-05-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2015-03-26 | 2015-02-28 | 0.09 | 0.08 | -0.01 | 11 | ||
2014-12-18 | 2014-11-30 | 0.08 | 0.08 | 0.0 | 0 | ||
2014-09-22 | 2014-08-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2014-07-22 | 2014-05-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2014-03-25 | 2014-02-28 | 0.07 | 0.07 | 0.0 | 0 | ||
2013-12-19 | 2013-11-30 | 0.08 | 0.06 | -0.02 | 25 | ||
2013-09-24 | 2013-08-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2013-07-23 | 2013-05-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2013-03-26 | 2013-02-28 | 0.07 | 0.07 | 0.0 | 0 | ||
2012-12-20 | 2012-11-30 | 0.07 | 0.07 | 0.0 | 0 | ||
2012-09-25 | 2012-08-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2012-07-24 | 2012-05-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2012-03-27 | 2012-02-29 | 0.05 | 0.06 | 0.01 | 20 | ||
2011-12-22 | 2011-11-30 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-09-27 | 2011-08-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-07-26 | 2011-05-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2011-03-22 | 2011-02-28 | 0.05 | 0.05 | 0.0 | 0 | ||
2011-01-04 | 2010-11-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2010-09-23 | 2010-08-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2010-07-20 | 2010-05-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2010-03-29 | 2010-02-28 | 0.04 | 0.04 | 0.0 | 0 | ||
2009-12-18 | 2009-11-30 | 0.05 | 0.05 | 0.0 | 0 | ||
2009-09-24 | 2009-08-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2009-07-21 | 2009-05-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2009-03-19 | 2009-02-28 | 0.03 | 0.03 | 0.0 | 0 | ||
2009-01-06 | 2008-11-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2008-09-24 | 2008-08-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2008-07-22 | 2008-05-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2008-03-25 | 2008-02-29 | 0.03 | 0.03 | 0.0 | 0 | ||
2008-01-03 | 2007-11-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2007-09-27 | 2007-08-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2007-07-24 | 2007-05-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2007-03-27 | 2007-02-28 | 0.02 | 0.02 | 0.0 | 0 | ||
2007-01-04 | 2006-11-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2006-09-26 | 2006-08-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2006-07-25 | 2006-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2006-03-23 | 2006-02-28 | 0.02 | 0.02 | 0.0 | 0 | ||
2006-01-05 | 2005-11-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2005-09-29 | 2005-08-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2005-07-26 | 2005-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2005-03-24 | 2005-02-28 | 0.02 | 0.02 | 0.0 | 0 | ||
2005-01-06 | 2004-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2004-09-29 | 2004-08-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2004-07-21 | 2004-05-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2004-03-25 | 2004-02-29 | 0.02 | 0.02 | 0.0 | 0 | ||
2004-01-07 | 2003-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2003-09-24 | 2003-08-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2003-07-22 | 2003-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2003-03-20 | 2003-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
2003-01-07 | 2002-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2002-09-25 | 2002-08-31 | 0.01 | 0.02 | 0.01 | 100 | ||
2002-07-24 | 2002-05-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2002-03-26 | 2002-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
2001-12-19 | 2001-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2001-09-24 | 2001-08-31 | 0.01 | 0.01 | 0.0 | 0 | ||
2001-07-24 | 2001-05-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2001-03-27 | 2001-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
2001-01-09 | 2000-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
2000-09-28 | 2000-08-31 | 0.01 | 0.01 | 0.0 | 0 | ||
2000-07-19 | 2000-05-31 | 0.01 | 0.01 | 0.0 | 0 | ||
2000-03-24 | 2000-02-29 | 0.01 | 0.01 | 0.0 | 0 | ||
1999-03-23 | 1999-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
1998-12-16 | 1998-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
1998-03-25 | 1998-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
1998-01-06 | 1997-11-30 | 0.02 | 0.02 | 0.0 | 0 | ||
1997-09-23 | 1997-08-31 | 0.02 | 0.02 | 0.0 | 0 | ||
1997-07-22 | 1997-05-31 | 0.01 | 0.01 | 0.0 | 0 | ||
1997-03-26 | 1997-02-28 | 0.01 | 0.01 | 0.0 | 0 | ||
1996-12-18 | 1996-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
1996-09-16 | 1996-08-31 | 0.01 | 0.01 | 0.0 | 0 | ||
null | null | null | null | null | 0 | ||
1996-03-27 | 1996-02-29 | 0.01 | 0.01 | 0.0 | 0 | ||
1995-12-29 | 1995-11-30 | 0.01 | 0.01 | 0.0 | 0 | ||
1995-10-03 | 1995-08-31 | 0 | 0.01 | 0.01 | 0 | ||
null | null | null | null | null | 0 | ||
1994-12-29 | 1994-11-30 | 0.01 | 0.01 | 0.0 | 0 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Neogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Neogen Corporate Management
Elected by the shareholders, the Neogen's board of directors comprises two types of representatives: Neogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neogen. The board's role is to monitor Neogen's management team and ensure that shareholders' interests are well served. Neogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bill Waelke | Head Relations | Profile | |
| Julie Mann | VP Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile | |
| David Naemura | Chief Officer | Profile | |
| Sarah Demey | Administrative Manager | Profile |
How to buy Neogen Stock?
The net worth of Neogen is the difference between its total assets and liabilities. Neogen's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Neogen's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Neogen's net worth can be used as a measure of its financial health and stability which can help investors to decide if Neogen is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Neogen stock.Already Invested in Neogen?
The danger of trading Neogen is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Neogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Neogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Neogen is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Neogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share 0.02 | Revenue Per Share 4.293 | Quarterly Revenue Growth 0.048 | Return On Assets 0.0179 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.